Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Universal Health Services (UHS)

Universal Health Services Q4 EPS rises to $4.96; 2025 EPS seen $18.45-$19.95

Positive Impact 3 of 5 earnings Written later

Universal Health Services reported fourth-quarter 2024 net income attributable to UHS of $332.4 million, or $4.96 per diluted share, up from $216.4 million, or $3.16, a year earlier, on net revenues up 11.1% to $4.114 billion. For full-year 2024, net income was $1.142 billion, or $16.82 per diluted share, on net revenues of $15.828 billion. The company forecast 2025 net revenues of $17.020 billion to $17.364 billion and EPS-diluted of $18.45 to $19.95 per share.

Key points

  • Q4 2024 net income attributable to UHS: $332.4 million, or $4.96 per diluted share, versus $216.4 million, or $3.16, in Q4 2023
  • Q4 2024 net revenues rose 11.1% to $4.114 billion; full-year 2024 net revenues were $15.828 billion
  • 2025 forecast: net revenues $17.020 billion to $17.364 billion; EPS-diluted $18.45 to $19.95 per share
  • Share repurchases in 2024 totaled approximately $598.5 million; about $824.4 million of authorization remained as of December 31, 2024

The filing

CompanyUniversal Health Services (UHS)
Form8-K, current report
Filed with the SECFeb 27, 2025, 8:45 AM ET
Accession number0000950170-25-028406

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.